Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)
Status:
Terminated
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This survey is being conducted to assess the safety and efficacy of niacin (+) laropiprant
(TREDAPTIVE) in usual practice in Korea according to the new product re-examination
regulations of the Korean Food and Drug Administration.